Clinical TrialID 911
Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C
NCT01292161
Hepatitis C
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 911
- Evidence Id
- 911
- Core Evidence Id
- 911
- Source Clinical Trial Id
- 893
- Herb2 Clinical Trial Id
- HBCT000893
- Nct Id
- NCT01292161
- Title
- Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C
- Status
- Completed
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Hepatitis C
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Silymarin
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Single
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult, Older_Adult
- Enrollment
- 55
- Outcome Measure
- Serum aminotransferases (ALT, AST), The investigators measured serum amino transferases by commercial AST kit,. ALT kits(Bayer Diagnostics,. Tarrytown, NY, USA) at six months after silymarin admission, at six months after admission
- Sponsor Collaborator
- Isfahan University of Medical Sciences
- Funded By
- OTHER
- Location
- Al-zahra university hospital, Isfahan, Iran, Islamic Republic of
- Other Id
- ASD-1213-15
- Start Date
- 2006-03
- Primary Completion Date
- 2006-09
- Completion Date
- 2006-09
- First Posted
- 2011-02-09
- Results First Posted
- Last Update Posted
- 2011-02-09
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01292161
- Title Cn
- Title En
- Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C
- Bilingual Status
- semi_complete